Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2010. Start Trial.
Date Value
November 02, 2026 9.763
October 30, 2026 9.814
October 29, 2026 9.754
October 28, 2026 9.440
October 27, 2026 9.362
October 26, 2026 9.429
October 23, 2026 9.508
October 22, 2026 9.057
October 21, 2026 7.499
October 20, 2026 7.656
October 19, 2026 7.148
October 16, 2026 7.164
October 15, 2026 7.227
October 14, 2026 7.048
October 13, 2026 6.934
October 12, 2026 7.133
October 09, 2026 7.146
October 08, 2026 7.116
October 07, 2026 7.149
October 06, 2026 7.104
October 05, 2026 7.072
October 02, 2026 7.212
October 01, 2026 7.096
September 30, 2026 7.260
September 29, 2026 7.361
Date Value
September 28, 2026 7.583
September 25, 2026 7.676
September 24, 2026 7.554
September 23, 2026 7.521
September 22, 2026 7.623
September 21, 2026 7.623
September 18, 2026 7.484
September 17, 2026 7.494
September 16, 2026 7.391
September 15, 2026 7.573
September 14, 2026 7.600
September 11, 2026 7.47
September 10, 2026 7.327
September 09, 2026 7.428
September 08, 2026 7.514
September 04, 2026 7.659
September 03, 2026 8.047
September 02, 2026 7.992
September 01, 2026 7.90
August 31, 2026 7.821
August 28, 2026 7.842
August 27, 2026 8.063
August 26, 2026 8.042
August 25, 2026 8.189
August 24, 2026 8.043

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Eli Lilly & Co. 31.71
Novo Nordisk A/S 5.190
Pfizer Inc. 1.771
Teva Pharmaceutical Industries Ltd. 5.706
Astellas Pharma, Inc. 2.411

Price to Book Value Related Metrics